欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/1455/001
药品名称
Repaglinide Stada 0.5 mg tablets
活性成分
Repaglinide 0.5 mg
剂型
Tablet
上市许可持有人
STADA Arzneimittel AG Germany
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Repaglinid STADA 0,5mg Tabletten
Belgium (BE)
Luxembourg (LU)
Austria (AT)
Edinimel 0,5 mg Tabletten
France (FR)
Spain (ES)
Italy (IT)
Sweden (SE)
Repaglinid STADA
Finland (FI)
Bulgaria (BG)
Indorin
Romania (RO)
Repaglinidă HF 0,5 mg comprimate
Slovenia (SI)
许可日期
2009/09/16
最近更新日期
2025/01/09
药物ATC编码
A10BX02 repaglinide
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
nlh1455_56_001_4_R_Updated FRAR_RMS
Date of last change:2024/09/06
Final Product Information
|
PL_Repaglinide_NL1455_20140523_tracked_akkoord
Date of last change:2024/09/06
Final Product Information
|
PL_Repaglinide_NL1456_20140523_tracked_akkoord
Date of last change:2024/09/06
Final Product Information
|
SmPC_Repaglinide_NL1455_20140523_tracked_akkoord
Date of last change:2024/09/06
Final Product Information
|
SmPC_Repaglinide_NL1456_20140523_tracked_akkoord
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase